These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37802886)

  • 1. Dysregulation of alternative splicing in spinocerebellar ataxia type 1.
    Olmos V; Thompson EN; Gogia N; Luttik K; Veeranki V; Ni L; Sim S; Chen K; Krause DS; Lim J
    Hum Mol Genet; 2024 Jan; 33(2):138-149. PubMed ID: 37802886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the ataxin-1 interaction network and its impact on spinocerebellar ataxia type 1.
    Chen JM; Chen SK; Jin PP; Sun SC
    Hum Genomics; 2022 Jul; 16(1):29. PubMed ID: 35906672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying Disease Signatures in the Spinocerebellar Ataxia Type 1 Mouse Cortex.
    Luttik K; Olmos V; Owens A; Khan A; Yun J; Driessen T; Lim J
    Cells; 2022 Aug; 11(17):. PubMed ID: 36078042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinocerebellar ataxia type 7 cerebellar disease requires the coordinated action of mutant ataxin-7 in neurons and glia, and displays non-cell-autonomous bergmann glia degeneration.
    Furrer SA; Mohanachandran MS; Waldherr SM; Chang C; Damian VA; Sopher BL; Garden GA; La Spada AR
    J Neurosci; 2011 Nov; 31(45):16269-78. PubMed ID: 22072678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'UTR-mediated regulation of Ataxin-1 expression.
    Manek R; Nelson T; Tseng E; Rodriguez-Lebron E
    Neurobiol Dis; 2020 Feb; 134():104564. PubMed ID: 31381977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect Negative Effect of Mutant Ataxin-1 on Short- and Long-Term Synaptic Plasticity in Mouse Models of Spinocerebellar Ataxia Type 1.
    Shuvaev AN; Belozor OS; Mozhei OI; Shuvaev AN; Fritsler YV; Khilazheva ED; Mosyagina AI; Hirai H; Teschemacher AG; Kasparov S
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.
    Chen HK; Fernandez-Funez P; Acevedo SF; Lam YC; Kaytor MD; Fernandez MH; Aitken A; Skoulakis EM; Orr HT; Botas J; Zoghbi HY
    Cell; 2003 May; 113(4):457-68. PubMed ID: 12757707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinocerebellar Ataxia Type 1 protein Ataxin-1 is signaled to DNA damage by ataxia-telangiectasia mutated kinase.
    Suart CE; Perez AM; Al-Ramahi I; Maiuri T; Botas J; Truant R
    Hum Mol Genet; 2021 May; 30(8):706-715. PubMed ID: 33772540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel function of Ataxin-1 in the modulation of PP2A activity is dysregulated in the spinocerebellar ataxia type 1.
    Sánchez I; Piñol P; Corral-Juan M; Pandolfo M; Matilla-Dueñas A
    Hum Mol Genet; 2013 Sep; 22(17):3425-37. PubMed ID: 23630944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An out-of-frame overlapping reading frame in the ataxin-1 coding sequence encodes a novel ataxin-1 interacting protein.
    Bergeron D; Lapointe C; Bissonnette C; Tremblay G; Motard J; Roucou X
    J Biol Chem; 2013 Jul; 288(30):21824-35. PubMed ID: 23760502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinocerebellar ataxia type 1--modeling the pathogenesis of a polyglutamine neurodegenerative disorder in transgenic mice.
    Clark HB; Orr HT
    J Neuropathol Exp Neurol; 2000 Apr; 59(4):265-70. PubMed ID: 10759181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in pathogenesis studies of spinocerebellar ataxia type 1.
    Cummings CJ; Orr HT; Zoghbi HY
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1079-81. PubMed ID: 10434309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.
    Ramani B; Panwar B; Moore LR; Wang B; Huang R; Guan Y; Paulson HL
    Hum Mol Genet; 2017 Sep; 26(17):3362-3374. PubMed ID: 28854700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of Wnt-β-catenin signaling in Purkinje cells and Bergmann glia in spinocerebellar ataxia type 1.
    Luttik K; Tejwani L; Ju H; Driessen T; Smeets CJLM; Edamakanti CR; Khan A; Yun J; Opal P; Lim J
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2208513119. PubMed ID: 35969780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract.
    Yue S; Serra HG; Zoghbi HY; Orr HT
    Hum Mol Genet; 2001 Jan; 10(1):25-30. PubMed ID: 11136710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acids in a region of ataxin-1 outside of the polyglutamine tract influence the course of disease in SCA1 transgenic mice.
    Skinner PJ; Vierra-Green CA; Emamian E; Zoghbi HY; Orr HT
    Neuromolecular Med; 2002; 1(1):33-42. PubMed ID: 12025814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Widespread alternative splicing dysregulation occurs presymptomatically in CAG expansion spinocerebellar ataxias.
    Shorrock HK; Lennon CD; Aliyeva A; Davey EE; DeMeo CC; Pritchard CE; Planco L; Velez JM; Mascorro-Huamancaja A; Shin DS; Cleary JD; Berglund JA
    Brain; 2024 Feb; 147(2):486-504. PubMed ID: 37776516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the glutamine expansion: influence of posttranslational modifications of ataxin-1 in the pathogenesis of spinocerebellar ataxia type 1.
    Ju H; Kokubu H; Lim J
    Mol Neurobiol; 2014 Dec; 50(3):866-874. PubMed ID: 24752589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.
    Garden GA; La Spada AR
    Cerebellum; 2008; 7(2):138-49. PubMed ID: 18418675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy.
    Keiser MS; Boudreau RL; Davidson BL
    Mol Ther; 2014 Mar; 22(3):588-595. PubMed ID: 24419082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.